Related by context. All words. (Click for frequent words.) 75 monoclonal antibodies 73 therapeutic monoclonal antibodies 71 therapeutic antibody 69 therapeutics 67 RNAi therapeutic 67 immunotherapeutics 67 monoclonal antibody 67 antibody therapeutics 66 antisense drugs 66 small molecule 66 biotherapeutics 65 cancer therapeutics 65 humanized antibody 64 microRNA therapeutics 64 siRNA therapeutics 64 humanized antibodies 64 recombinant antibodies 63 anticancer compounds 63 antibody 63 human antibody therapeutics 63 therapeutic monoclonal antibody 62 therapeutic proteins 62 polyclonal antibodies 62 oncolytic 62 small molecule therapeutics 62 Nanobody 62 humanized monoclonal antibodies 62 novel peptide 62 IAP inhibitors 62 anticancer agents 62 Nanobodies ® 62 recombinant polyclonal antibodies 61 RNAi therapeutics 61 Nanobody ® 61 aptamers 61 protein therapeutics 61 epothilone 61 novel antibody therapeutics 61 oncology therapeutics 61 anticancer therapeutics 61 humanized monoclonal antibody 61 polymerase inhibitors 61 Nanobodies R 61 cancer immunotherapies 61 siRNA therapeutic 61 fusion proteins 61 monoclonal antibodies MAbs 61 Nanobodies 60 aptamer therapeutics 60 siRNA delivery 60 immunological diseases 60 monoclonal 60 immunotherapeutic 60 RNAi 60 Vaccinex 60 biomarker discovery 60 rxRNA 60 novel therapeutics 60 OncoVEX 60 MOR# 60 small molecule inhibitors 60 preclinical 60 cancer immunotherapy 60 PEGylated 60 RNA interference RNAi therapeutics 60 antiviral therapeutics 60 mAbs 60 NEUGENE R 60 OncoVEX GM CSF 59 MAbs 59 human monoclonal antibody 59 adrenal steroid hormones 59 immunotherapies 59 ALN VSP 59 novel peptides 59 anticoagulant reversing agent 59 affinity antibodies 59 antibody therapies 59 XmAb 59 siRNA 59 UltiMAb 59 prophylactic vaccines 59 oncolytic viruses 59 preclinical compounds 59 stem cell therapeutics 59 NEUGENE 59 Scancell 59 novel anti infective 59 NTDDS 59 LEX System 59 PER.C6 ® 59 Dicer Substrate Technology 59 DOS# 59 KineMed 59 mAb 59 HuCAL 58 Tarvacin TM 58 recombinant vaccines 58 Cellzome 58 antisense drug 58 Tranzyme 58 vaccine adjuvants 58 siRNA sequences 58 MVA BN R 58 recombinant protein 58 rxRNA compounds 58 HuCAL antibody 58 Vegenics 58 dAbs 58 peptide therapeutics 58 NovaBay Aganocide compounds 58 ImmunoGen 58 MEK inhibitor 58 antiviral compounds 58 Lpath 58 SCYNEXIS 58 iPSC technology 58 biologic therapeutics 58 MEK inhibitors 58 chemical entities NCEs 58 Sangamo ZFP technology 58 Pancreate 58 BiTE antibody 58 anti infective 58 biopharmaceuticals 58 AAV vector 57 proprietary phage display 57 Symphogen 57 ETBs 57 monoclonal antibodies mAbs 57 Adnectin 57 Plexxikon 57 shRNA libraries 57 siRNA compounds 57 Monoclonal antibodies 57 LNP formulations 57 AAV vectors 57 HTS assay 57 biotherapeutic 57 Anaphore 57 phage display 57 RNAi therapeutic targeting 57 ALN TTR 57 CEQ# 57 antibody fragments 57 RNA interference RNAi 57 DNA plasmids 57 Onalta 57 Ambrx 57 epothilones 57 antibody fragment therapeutics 57 Epitomics 57 antibodies 57 Scil Proteins 57 miRNA therapeutics 57 BCR ABL inhibitors 57 anti CD# antibodies 57 Guanilib 57 drug conjugates ADCs 57 G Protein Coupled 57 monoclonal antibody therapeutics 57 LNPs 57 aTyr Pharma 57 MDRNA proprietary 57 Intellikine 57 nitric oxide donating 57 BiTE 57 oral antiviral 57 epigenetic enzymes 57 novel immunomodulatory 57 targeted radiotherapeutic 57 A3 adenosine receptor 57 drug conjugate 57 Crucell PER.C6 ® 56 SARMs 56 MediVas 56 OGeS 56 recombinant proteins 56 PORxin TM 56 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 56 GPCR 56 Receptos 56 nanoviricides 56 anticancer drugs 56 oncolytic virus 56 Pfenex 56 GAP #B# 56 targeting CD# 56 romazarit 56 tiapamil 56 Phylomer ® 56 TRAIL receptor antibodies 56 TLR9 agonists 56 FoldRx 56 lentiviral vectors 56 immunotherapy 56 INxin TM 56 prostone 56 TOPIGEN 56 antisense 56 Anticalins R 56 ddRNAi 56 HCV antiviral 56 vaccine adjuvant 56 tkRNAi 56 Fleximer 56 selective androgen receptor modulators 56 Avila Therapeutics 56 Nasdaq MITI biopharmaceutical 56 immune modulators 56 aptamer 56 ATL# [002] 56 kinase inhibitors 56 catalytic antioxidant compounds 56 CAMBRIDGE Mass. Alnylam Pharmaceuticals 56 LentiVector technology 56 histone methyltransferases HMTs 56 diagnostic biomarkers 56 Antigen Express 56 Viprovex TM 56 Serenex 56 novel antiviral therapeutics 56 Mersana Therapeutics 56 Acuity Pharmaceuticals 56 AEG# 56 isoform selective 56 ALN TTR# 56 HGS ETR1 56 bioactive lipids 56 IMC #B 56 PORxin TM platforms 56 Hsp# inhibitor 56 antiviral therapies 56 therapeutic peptide 56 UltiMAb ® 56 THR beta agonist 56 Curaxin 56 proteasome inhibitor 56 Medarex UltiMAb R 56 Ore Pharmaceuticals 56 oncology 56 antisense inhibitors 56 Zenyaku Kogyo 56 recombinant polyclonal antibody 56 Anacor 56 investigational therapies 55 antibody fragment 55 novel RNAi therapeutics 55 Adenosine Therapeutics 55 ALN PCS 55 HepDirect R 55 imaging radiopharmaceuticals 55 Novosom 55 DPX Survivac 55 functional genomics 55 TÎ ² 4 55 synthetic retinoid 55 CD# CEA 55 protein kinase inhibitors 55 novel immunotherapies 55 hyaluronidase rHuPH# 55 MorphoSys 55 GPCR targets 55 proteomics 55 biased ligand 55 VentiRx 55 liposomal 55 companion diagnostics 55 Archemix 55 Locked Nucleic Acid LNA 55 Aeolus Pharmaceuticals 55 ImmunoGen Inc. 55 mucosal vaccines 55 Agensys 55 Transfluor 55 Nasdaq MBRX announced 55 VaxInnate 55 PROfusion 55 Tolerx 55 DsiRNA 55 antisense therapeutics 55 ChemoCentryx 55 commercializing anti infective 55 Hsp# inhibitors 55 Nasdaq PARD biopharmaceutical 55 Cylene 55 Dyax phage display 55 delta isoform 55 Transdel TM 55 peptide antigens 55 Stapled Peptide 55 VitiGam 55 transfection reagents 55 Atiprimod 55 anticancer therapies 55 Anticalin 55 Selective Electrochemical Tumor Ablation 55 GRNVAC1 55 RNA therapeutics 55 TLR9 agonist 55 short interfering RNA 55 Cyclosert 55 Aganocide ® 55 vascular disrupting agents 55 XmAb ® 55 monoclonal antibody MAb 55 biopharmaceutical 55 adenoviral 55 HIV integrase inhibitors 55 inflammatory diseases 55 FivePrime 55 biologic therapies 55 zinc finger nuclease 55 histone deacetylase HDAC inhibitors 55 Intarcia 55 novel therapeutic antibodies 55 lentiviral vector 55 humanized anti 55 CTLA4 Ig 55 BioWa 55 JAK2 inhibitor 55 synthetic siRNA 55 vaccine GRNVAC1 55 CD# monoclonal antibody 55 theranostics 55 DepoVax TM 55 Hybridon 55 RNA antagonists 55 HuLuc# 55 M2 subunit 55 TLR Therapeutics 55 Galenea 55 NexACT 55 gastro intestinal inflammation 55 recombinant adeno associated 55 nanomedicines 55 investigational monoclonal antibody 55 Anticalins 55 antisense oligonucleotides 55 small molecule modulators 55 IgG1 antibody 55 HSP# inhibitor 55 RayBiotech 55 systemic RNAi 55 Chemokine Therapeutics 54 Lycera 54 AP# [003] 54 Cyclosert TM 54 otelixizumab 54 PEGylation technology 54 LentiVector 54 selective inhibitors 54 RONDEL ™ 54 mda 7 54 Exelixis compounds 54 bioinnovation 54 Omacetaxine 54 HCV polymerase inhibitors 54 Aganocide 54 purinergic receptors P#X# 54 liposomal delivery 54 proprietary LNA 54 anti infective treatments 54 Neugene 54 Azedra 54 PI3K inhibitors 54 hematological cancers 54 Affibody ® molecules 54 SR Pharma 54 GlycArt 54 oxidative stress inducer 54 TLR8 54 proprietary PEGylation 54 InNexus Biotechnology 54 Charlesson 54 Spiegelmers ® 54 antagomirs 54 OMP #M# 54 Receptors GPCRs 54 preclinical toxicology 54 antibody MAb 54 Semafore 54 Sym# 54 oncology indications 54 oral prodrug 54 preclinical models 54 bispecific antibody 54 topical anti infective 54 Ceflatonin 54 Alfacell proprietary ribonuclease 54 ESBA# 54 anti infectives 54 OncoMed 54 HepDirect 54 attach auristatin 54 targeted immunotherapies 54 PEGylation 54 therapeutic 54 Micromet BiTE 54 JAK1 54 engineered proteases 54 Kleanthis G. Xanthopoulos Ph.D. 54 monoclonal antibody mAb 54 ProNAi 54 Aquinox 54 Epothilones 54 investigational humanized monoclonal antibody 54 Biolex 54 novel immunotherapeutic 54 MT#/MEDI-# 54 Inovio 54 small molecule agonists 54 recombinant albumin 54 OriGene 54 Archexin 54 AVEO 54 FoldRx Pharmaceuticals Inc. 54 Idera Pharmaceuticals 54 peptides 54 molecular diagnostics 54 targeted anticancer therapeutics 54 Proxinium TM 54 MaxCyte 54 ophthalmic diseases 54 Nasdaq ENZN 54 biomarkers 54 NXL# 54 VLP vaccine 54 proteasome inhibitors 54 MolecularBreeding TM 54 Amunix 54 dSLIM 54 DXL# 54 medicinal chemistry 54 Nasdaq HALO 54 UsiRNAs 54 ZFP technology 54 protein kinase inhibitor 54 XmAb TM 54 HGS# 54 Isogenica 54 monoclonals 54 Inc. OTCBB LPTN 54 intranasal insulin product 54 Mpex 54 FASgen 54 microRNA miRNA 54 Factor VIIa 54 FGFR 54 molecular chaperone regulation 54 Sorrento Therapeutics 54 Nautilus Biotech 54 CD# antibody [001] 54 myelofibrosis polycythemia vera 54 recombinant vaccine 54 GPR# agonist 54 oligonucleotide therapeutics 54 CombinatoRx 54 Allovectin 7 R 54 CYC# 54 biomarker assays 54 Morphotek 54 Panzem 54 Jennerex 54 oxazolidinone 54 hemorrhagic fever viruses 54 DispersinB ® 54 Exherin TM 53 Chimerix 53 cytoskeleton enables 53 immuno inflammatory diseases 53 SIMPLE Antibody TM 53 commercialize microRNA 53 DECIPHER R 53 BioSeek 53 HGS ETR1 mapatumumab 53 CXCR4 receptor 53 Sphingomab TM 53 Nektar PEGylation technology 53 PsychoGenics 53 SAR# [002] 53 XmAb# 53 Radilex 53 Syrrx 53 CCX# 53 generation antisense 53 biosurgical 53 Dicerna 53 Alnylam RNAi 53 Targeted Chemotherapy 53 immunomodulators 53 JAK inhibitor 53 Tarvacin 53 InNexus 53 pharmacological chaperone 53 Medarex 53 daptomycin 53 glucokinase activator 53 SMaRT ™ 53 biocatalysis 53 molecular biomarkers 53 Affimed Therapeutics AG 53 BioMAP ® Systems 53 CCR9 antagonist 53 novel kinase inhibitors 53 AVP #D# 53 using ImmunoGen TAP 53 fusion protein 53 HCV polymerase 53 CR# vcMMAE 53 subunit vaccine 53 commercialize microRNA therapeutics 53 atacicept 53 Micromet proprietary BiTE 53 H#N# VLP vaccine 53 HDAC inhibition 53 Amira Pharmaceuticals 53 Locked Nucleic Acid 53 lipid nanoparticles 53 MacroGenics 53 immatics 53 virosome 53 Antibody 53 ATG Fresenius S 53 Aganocide compounds 53 DepoVax ™ 53 HepeX B 53 PDE4 inhibitor 53 NanoViricides 53 Merrimack Pharmaceuticals 53 Ii protein 53 Caprion 53 Azixa 53 AvalonRx R 53 Phage Pharmaceuticals 53 virus AAV 53 biomarker identification 53 antigen rPA anthrax 53 PORxin 53 Alnylam 53 boron chemistry 53 DepoVax 53 microtubule inhibitor 53 Adnexus Therapeutics 53 orally bioavailable 53 ImmunGene 53 Campath ® 53 molecularly targeted 53 Archemix Corp. 53 nicotinic alpha 7 53 immune modulation 53 Celator 53 Monoclonal antibody 53 CB1 antagonists 53 Sphingomab 53 renin inhibitors 53 Solazed 53 Tumor Activated Prodrug TAP 53 biobetter 53 TKM PLK1 53 proprietary Dicer Substrate Technology 53 covalent drugs 53 MVA BN 53 PLK1 SNALP 53 VelocImmune 53 phage display libraries 53 Gemin X 53 ocular diseases 53 Anticalin R 53 Affitech AS 53 Nasdaq CYTR biopharmaceutical 53 OTCBB PYTO FWB ET6 53 polyketides 53 molecular diagnostic 53 ImmuneRegen BioSciences Inc. 53 Fleximer R 53 OTCBB NVLT biopharmaceutical 53 Onconase 53 trastuzumab DM1 T DM1 53 ProtAffin 53 NASDAQ CYTR biopharmaceutical 53 Pentad TM 53 potently inhibit 53 HuMax CD# 53 Isis antisense 53 POTELLIGENT R 53 NEUGENE antisense 53 telomerase therapeutic 53 molecular chaperone amplification 53 immune stimulatory 53 Nasdaq HALO biopharmaceutical 53 antigen sparing 53 predictive biomarkers 53 IAP inhibitor 53 immune modulatory 53 Helix BioMedix 53 NASDAQ ABII 53 NASDAQ DYAX 53 PSMA ADC 53 Pfenex Expression Technology 53 XmAb ™ 53 chemically modified siRNA 53 KemPharm 53 HDAC inhibitor 53 Tarmogen 53 Kyowa Hakko Kirin 53 Tarvacin Anti Viral 53 ArQule Kinase Inhibitor Platform 53 Acetylon 53 AAG geldanamycin analog 53 NovaBay 53 Ramoplanin 53 nanobodies 53 MCSP respectively 53 Immunomedics Inc. 53 JAK3 53 immunomodulator 53 AMEX ONI 53 CORT # 53 MMAE 53 immunologic diseases 53 exon skipping 53 ImmunoGen TAP technology 53 Payload TAP technology 53 ADME Tox 53 AMPK activators 53 AtuRNAi 53 OXIGON TM 53 lipidomics 53 RNA interference 53 adrenergic regulation 53 Cempra 53 ophthalmic therapeutics 53 Nexavar ® 53 Provectus Pharmaceuticals specializes 53 Mersana 53 metaglidasen 53 synthetic peptides 53 Phylomer 53 AVEO integrates proprietary 53 Stapled Peptides 53 sodium glucose transporter 53 New Chemical Entities 53 NYSE Amex PBTH 53 anti CD# antibody 53 Zolinza 53 IMA# 53 HCV protease inhibitors 53 BHT DNA 53 CB2 selective 53 Aegis Therapeutics 53 flu mAb 53 skeletal muscle contractility 53 CBLC# 53 adenoviral vectors 52 POTELLIGENT ® 52 ADCC enhanced 52 renin inhibitor 52 Oncaspar 52 Metabolex 52 Versartis 52 AbD Serotec 52 ANG# 52 OvaRex R 52 EndoTAG 52 chemotherapeutics 52 selective androgen receptor modulator 52 StromaCel Inc. 52 therapeutic mAbs 52 humanized monoclonal 52 RNA antagonist 52 Cellgate Inc. 52 PRNewswire FirstCall Nastech Pharmaceutical 52 protein biomarkers 52 AKIP ™ 52 Tekmira SNALP technology 52 tranilast 52 nucleic acid 52 BioFocus 52 molecular chaperone 52 short hairpin RNAs 52 PROT biotechnology 52 Listeria vaccine 52 Squalamine 52 Affimed 52 RGB # 52 Viamet 52 histone deacetylase HDAC 52 NASDAQ LGND 52 GPCRs 52 Angiocept 52 IMC A# 52 microRNAs 52 Innovive 52 Aegera Therapeutics 52 orphan GPCRs 52 recombinant protein therapeutics 52 microRNA sequences 52 phage display technology 52 cyclophilin inhibitors 52 antibody reagents 52 Virulizin 52 Aurora kinase inhibitor 52 nanoviricide 52 DiLA2 52 Viventia 52 regenerative therapies 52 CD3 monoclonal antibody 52 Etubics 52 gene silencing 52 Symadex 52 anti EGFR antibody 52 HCV protease inhibitor 52 TPI ASM8 52 protein antigens 52 Domantis 52 Minapharm 52 HCD# [002] 52 Metabasis Therapeutics Inc. 52 JAK2 inhibitors 52 siRNAs 52 Quark Biotech Inc. 52 MAXY G# 52 prodrugs 52 PEG Interferon lambda 52 Innovive Pharmaceuticals 52 recombinant antibody 52 rheumatoid arthritis multiple sclerosis 52 XL# XL# 52 Celldex 52 Juvaris 52 Panzem R 52 Ibis T# TM 52 immunotherapeutic approaches 52 Neurimmune 52 viral vectors 52 Homspera 52 rxRNA ™ compounds 52 viral diseases 52 OMJPI 52 ActivX 52 SensiGen 52 RAV# 52 GelSite R polymer 52 TRAIL receptor 52 Nuron Biotech 52 entinostat 52 ZFPs 52 PNT# 52 Zingo TM 52 ERYtech Pharma 52 Ceregene 52 NPC 1C 52 RECOTHROM R 52 AnaptysBio 52 Maxy G# 52 Aegera 52 MAb 52 triggers apoptosis programmed 52 HIV integrase inhibitor 52 Agios Pharmaceuticals 52 alvespimycin 52 therapeutic modalities 52 TransMolecular 52 HuCAL antibodies 52 Poly ICR 52 OncoVex 52 HSP# inhibitors 52 oligonucleotide 52 Panzem R NCD 52 dAb 52 EndoTAG TM 52 Nanobiotix 52 synthetic cannabinoid compounds 52 RECOTHROM ® 52 herpes simplex viruses 52 Alnylam Pharmaceuticals 52 Calistoga Pharmaceuticals 52 dependent cellular cytotoxicity 52 Diatos 52 TOCOSOL Camptothecin 52 oncolytic virus therapies 52 immunomodulatory 52 Synta 52 GRN#L 52 metabolite identification 52 GLPG# 52 SGLT Inhibitors 52 biodefense pathogens 52 biologically validated targets 52 Harbor BioSciences 52 Nanobodies ® novel 52 Galderma SA 52 Anticalins ® 52 ENMD # 52 Nasdaq VRTX 52 selective kinase inhibitors 52 Potelligent Technology 52 Epizyme 52 lipid nanoparticle 52 Biolex Therapeutics 52 Enzo Therapeutics 52 Biogen Idec NASDAQ BIIB 52 EHT AGN 52 systemic siRNA 52 prophylactic vaccine 52 Azedra TM 52 using Crucell PER.C6 52 immunotoxins 52 Homspera TM 52 NuMimetic TM 52 tubulin inhibitor 52 anionic backbone 52 Kosan dependence 52 PentaStaph 52 Inc. OTCBB IRBS 52 selective immunoproteasome inhibitor 52 tumor antigens 52 immunotherapeutic vaccine 52 rxRNA TM compounds 52 SNALP technology 52 Inc. NASDAQ CRIS 52 Nasdaq RXII 52 OPKO 52 regenerative therapeutics 52 Vaxfectin TM 52 Chimigen 52 Bioral 52 intranasal delivery 52 staphylococcal vaccine 52 lentiviral 52 ASONEP 52 telomerase activators 52 selective orally bioavailable 52 Aerovance 52 ZFP TFs 52 hematological malignancies 52 Viprovex R 52 vaccines oncolytic virus 52 Melior Discovery 52 Graffinity 52 polymer conjugate technology 52 anti CD3 monoclonal 52 LEAPS TM 52 belinostat 52 Curaxins 52 biomarker assay development 52 SNALP 52 ADMETRx 52 Solazed TM 52 OxBC 52 Onco TCS 52 #ME# 52 Immuron 52 Ception Therapeutics 52 MTP inhibitor 52 GelSite polymer 52 VaxImmune 52 personalized immunotherapy 52 vinca alkaloid 52 PARP inhibitors 52 ibudilast 52 NP2 Enkephalin 52 diagnostic molecular imaging 52 Endotis 52 autoimmune diseases 52 Olaparib 52 AGS PSCA 52 zanolimumab 52 Elesclomol 52 siRNAs targeting 52 AdVac ® 52 CNS disorders 52 Pacira 52 anti CD# monoclonal 52 theranostic 52 DNAi 52 polyclonal 52 VEGF Trap 52 MyVax R 52 L BLP# 52 NP2 52 inhibit metastasis 52 systemic RNAi therapeutic 52 dermatology therapies 52 Callisto Pharmaceuticals Inc. 52 enveloped viruses 52 polyclonal antibody 52 TKM ApoB 52 bafetinib 52 Pepducin 52 radezolid 52 ribonucleotide reductase clinically validated 52 thymalfasin 52 Achaogen 52 monoclonal antibody therapies 52 predictive toxicology 52 equine osteoarthritis 52 Bicifadine 52 CobaCyte 52 novel anticancer 52 ErbB3 52 Cethrin R 52 recombinant 52 R#/MEM # 52 chronic viral infections 52 Virulizin ® 51 combinatorial chemistry 51 Lupuzor 51 Raven Biotechnologies 51 Smac mimetics 51 ChimeriVax JE 51 ATL# [001] 51 proprietary BiTE ® 51 epigenetic therapeutics 51 Fibroblast Growth Factor Receptor 51 recombinant biopharmaceutical 51 siRNA constructs 51 PharmFilm ® 51 Apexigen 51 diagnostic assays 51 coagulation factor VIIa 51 Veronate 51 metalloenzymes 51 ZFP Therapeutic 51 stable nucleic acid 51 Therapeutic antibodies 51 active personalized immunotherapies 51 Biotie 51 IR BioSciences Holdings 51 KaloBios 51 P#X# 51 IRX 2 51 Oxford BioMedica 51 sirtuin therapeutics 51 nasal powder 51 ophthalmology oncology 51 XenoMouse 51 Tesetaxel 51 Talabostat 51 SMARTICLES ® 51 humanised monoclonal antibody 51 EB# ® 51 angioedema indications 51 anthrax monoclonal antibody 51 Genasense evaluating 51 preclinically 51 Kalypsys 51 Nanoviricides 51 patented NanoStat TM 51 echinocandins 51 fusion inhibitor 51 crofelemer 51 BACcel 51 interferon lambda 51 hematologic diseases 51 CytRx Corporation 51 NASDAQ OPXA 51 deacetylase inhibitors 51 prostate cancer antigen prostatic 51 platinum chemotherapeutic 51 chemogenomics 51 promising anticancer 51 Merck Serono division 51 Litx 51 identify protein biomarkers 51 Fc fusion protein 51 radiation sensitizer 51 Novavax VLP vaccine 51 Stemgent 51 Chemetics R 51 Nimotuzumab 51 Myocet 51 antibacterial compounds 51 protein tyrosine phosphatase 1B 51 recombinant protective 51 oral proteasome inhibitor 51 AVI NEUGENE 51 Corixa Corporation 51 VEGF receptor 51 vascular disrupting agent 51 TAFA# 51 Golimumab 51 Immunotope 51 Evotec 51 Ustekinumab 51 taxane derivative 51 Afferent Pharmaceuticals 51 GM CSF 51 nonviral 51 Onalta TM 51 Regado 51 NASDAQ CYTR 51 XL# anticancer compounds 51 stranded LNA 51 Chemokine 51 LEAD Therapeutics 51 ganetespib 51 chimeric antibodies